Industry News
Ocean study alters view of global warming
By measuring nitrogen and phosphorus levels in a sediment core off western Mexico, an international research team led by Edinburgh University's Dr Raja Ganeshram, concludes that climatic change may be a more complex process than was previously thought.
[ + ]WA farmers establish GMO policy
The Western Australian Farmers Federation (WA Farmers) has released its policy on genetically modified organisms. [ + ]
Macquarie Bank to advise on synchrotron
Macquarie Bank has been appointed as financial adviser to the Victorian government's $157 million synchrotron project. [ + ]
Plant genomics centre gets new funding boost
The NSW Centre for Agricultural Genomics will expand, after recieving the first injection of funds from the NSW government's BioFirst Intitiative. [ + ]
Pestat hires CSIRO researcher to assist development
Early-stage biotech Pestat is developing biological control products based around controlling fertility of pest animals. [ + ]
ES Cell to supply stem cell lines to US govt
Melbourne's ES Cell International will supply embryonic stem cells to the National Institutes of Health (NIH) - the first company outside the United States to enter such an arrangement with the biomedical powerhouse. [ + ]
Lawyers push for new agency to keep up with science
The Australian Law Reform Commission may recommend the Howard government create an Australian equivalent of the UK Human Genetics Commission. [ + ]
Positive result for MicroMedical heart device
Manufacturing has begun on the final version of MicroMedical Industries' VentrAssist artificial heart device. [ + ]
State funding for six NSW start-ups
Six early-stage biotechnology companies will share $649,000 in NSW government grants to assist in taking their biomedical technologies through to commercialisation. [ + ]
Investment company seeks to invest $50 million in biotech
Australian Technology Innovations Fund (ATIF), a Brisbane-based private investment company, is seeking to invest $50 million in biotechnology projects and companies. [ + ]
Ethical thumbs-up for Metabolic obesity drug trial
Metabolic Pharmaceuticals has gained ethics approval to begin testing its oral obesity drug in patients. [ + ]
Circadian to invest in memory, brain research
Circadian Technologies will invest almost $450,000 over the next 18 months in two new projects, the development company announced today. [ + ]
Progen scores half-million manufacturing deal
US biotech Lipid Sciences has signed a $500,000 manufacturing pact with Progen Industries, boosting Progen's already-thriving contract drug manufacturing arm. [ + ]
Peptech expects to cash in on Abbott drug approval
A rheumatoid arthritis treatment developed by Sydney biotech Peptech could become the first of its monoclonal antibodies to hit the market, if drug giant Abbott Laboratories wins approval to market the drug Adalimumab in the US and Europe. [ + ]
Qld government moves to shore up R&D framework
Queensland's Cabinet has kicked off a sweeping effort to set in place a long-term R&D framework in place for emerging industries. [ + ]
